Related Experiment Video

Updated: Mar 27, 2026

An Optimized Hemagglutination Inhibition HI Assay to Quantify Influenza-specific Antibody Titers
06:34

An Optimized Hemagglutination Inhibition HI Assay to Quantify Influenza-specific Antibody Titers

Published on: December 1, 2017

38.4K

Influenza Vaccine Effectiveness: Mysteries, Enigmas, and a Few Clues

Andrew T Pavia1

  • 1Division of Pediatric Infectious Diseases, University of Utah School of Medicine, Salt Lake City.

The Journal of Infectious Diseases
|January 9, 2016
PubMed
Abstract

No abstract available in PubMed .

Keywords:
case-control studiesinfluenza vaccineinfluenza vaccine effectivenessinfluenza virusvaccine effectiveness

More Related Videos

Measuring Influenza Neuraminidase Inhibition Antibody Titers by Enzyme-linked Lectin Assay08:11

Measuring Influenza Neuraminidase Inhibition Antibody Titers by Enzyme-linked Lectin Assay

Published on: September 6, 2016

20.0K
Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes08:52

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes

Published on: July 26, 2019

8.7K

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
53.6K
Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
37